DaVita Inc. (NYSE:DVA) Receives Average Rating of “Hold” from Analysts

DaVita Inc. (NYSE:DVA) has earned an average rating of “Hold” from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $164.50.

Several research firms recently commented on DVA. Truist Financial cut their price objective on shares of DaVita from $170.00 to $164.00 and set a “hold” rating for the company in a report on Monday, May 19th. Wall Street Zen raised shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th.

Hedge Funds Weigh In On DaVita

A number of hedge funds have recently modified their holdings of the company. Wellington Management Group LLP boosted its position in shares of DaVita by 9.1% during the fourth quarter. Wellington Management Group LLP now owns 2,711 shares of the company’s stock worth $405,000 after acquiring an additional 227 shares during the last quarter. Fifth Third Bancorp boosted its position in shares of DaVita by 5.0% during the first quarter. Fifth Third Bancorp now owns 4,274 shares of the company’s stock worth $654,000 after acquiring an additional 204 shares during the last quarter. Concurrent Investment Advisors LLC bought a new position in shares of DaVita during the first quarter worth $223,000. Wealth Enhancement Advisory Services LLC lifted its position in DaVita by 22.5% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company’s stock valued at $666,000 after purchasing an additional 800 shares during the last quarter. Finally, OneDigital Investment Advisors LLC bought a new position in DaVita during the first quarter valued at $200,000. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Up 2.2%

DaVita stock opened at $143.35 on Friday. DaVita has a twelve month low of $131.76 and a twelve month high of $179.60. The firm has a 50 day moving average price of $140.16 and a 200-day moving average price of $148.63. The company has a market capitalization of $10.82 billion, a P/E ratio of 14.21, a P/E/G ratio of 0.98 and a beta of 1.11. The company has a quick ratio of 1.20, a current ratio of 1.25 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last released its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.75 by $0.25. The company had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. DaVita had a net margin of 6.63% and a return on equity of 176.11%. DaVita’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same period last year, the firm earned $2.26 EPS. As a group, equities analysts predict that DaVita will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.